News & Announcements
Good Results With SBRT Plus Erlotinib in Limited but Progressive Metastatic NSCLC
In a phase II study reported in the Journal of Clinical Oncology, Lyengar et al found that stereotactic body radiation therapy plus Erlotinib resulted in infrequent recurrence in radiation therapy-treated sites and was associated with prolonged progression-free survival and overall survival in patients with limited but progressive metastatic non-small cell lung cancer.
Cancer researchers identify irreversible inhibitor for KRAS gene mutation
UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.
Department receives $3 million for recruiting faculty
The Department of Radiation Oncology has been awarded $3 million to recruit a leading expert in particle radiobiology. This high-profile award by the Cancer Prevention and Research Institute of Texas (CPRIT) was part of an $11 million award to UT Southwestern announced May 22.
Video game processors to improve cancer patient care
Medical physicists at UT Southwestern Medical Center are finding new ways to use the speed of video game processors to promote research that is aimed at improving patient care.
Blocking DNA repair could improve radiation therapy for brain cancer
UT Southwestern Medical Center researchers have demonstrated in both cancer cell lines and in mice that blocking critical DNA repair mechanisms could improve the effectiveness of radiation therapy for highly fatal brain tumors called glioblastomas.
Possible world's first: Physicians use CyberKnife to treat vocal cord cancer
Stephen Wiley went from being a life-long cowboy to one of the world’s first patients to have vocal cord cancer treated by the CyberKnife, a robot that destroys tumors with highly precise doses of radiation.
Proton therapy center planned for North Texas
UT Southwestern, seeking to broaden an already robust array of radiation oncology treatments it offers to patients, will play a key role in operating a state-of-the-art proton therapy center for North Texas being planned and funded by San Diego-based Advanced Particle Therapy (APT).